Orchid Pharma Q2 Results

  • BSE: 524372
  • NSE: ORCHPHARMA
  • ISIN: INE191A01027
  • Sector: Biotechnology & Drugs
BSE
886.0028.50 (3.32%)
Volume3.90 K
Updated: Fri 13 Nov, 2026 | 15:26:49
NSE
884.4026.60 (3.10%)
Volume88.88 K
Updated: Fri 13 Nov, 2026 | 15:52:10
Today: 860.30
903.00
52-Wk: 471.30
1,142.65

Q2 Results Highlights

Quarter ended Sep 25

    Note: Comparison is on QoQ basis

    Quarterly - Orchid Pharma Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 25Jun 26QoQ CompSep 24YoY Comp
    Total Operating Expense 203.90301.12-27.01%200.991.45%
    Depreciation/ Amortization 8.9010.95-15.50%8.633.20%
    Operating Income -10.383.05-35.85%21.710.00%
    Net Income -5.723.220.55%27.240.00%
    Other Operating Expenses Total 37.6457.83-34.81%41.14-8.50%
    Net Income Before Taxes -3.332.65-51.61%25.900.00%
    Total Revenue 193.52304.17-26.47%222.70-13.10%
    Selling/ General/ Admin Expenses Total 24.8528.04-10.28%20.0623.89%
    Diluted Normalized EPS -1.130.5418.95%5.370.00%
    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market